Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions

Completed · Not applicable

Conditions studied: Osteochondral Lesions of Talus

In brief

The purpose of this study is to determine the clinical efficacy of the application of bone marrow aspirate concentrate (BMAC) as a supplement to microfracture in the treatment of osteochondral lesions of the talus (OLTs).

Key facts

Study ID

NCT02011295

Run by

Duke University

People needed

17

Starts

2014-01-29

Expected to finish

2019-06-26

Last updated by the study team

2019-08-16

Who can join

Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• over age 18
• has an OLT that has not had previous surgical treatment

You may not qualify if…

• OLT greater than 1.5cm in diameter (these require more extensive treatment)
• more than one OLT
• radiographic evidence of widespread ankle joint arthritis
• any systemic inflammatory disease
• any ankle deformity

Where it is running

• Duke Medical Plaza Page Road — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.